Paediatric Diseases Working Party (PDWP)
Study type:
Study number:
8417024
Type of Stem Cell Treatment:
Allogeneic
Diseases:
Acute Myeloid Leukaemia (AML)
Short title:
Primary objective:
To describe the clinical characteristics and outcomes (OS, DFS, NRM, relapse incidence) of pediatric patients with AML presenting with EMD and identify prognostic factors associated with improved outcome.
Key inclusion criteria:
All patients ≤18 years of age who are affected by extramedullary disease associated with AML any time prior to transplantation with or without bone marrow involvement and who underwent an allo-HCT between 2008 and 2017.
Country:
Principal investigator:
Kanchan Rao
EBMT Study coordinator:
Arnaud Dalissier